NMTC News and Press, NeuroOne Medical Technologies Corporation From 03/09/23

NeuroOne®#¹⁶⁰;to Participate in the 35th Annual Roth Conference PR Newswire EDEN PRAIRIE, Minn. , March 9, 2023 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology co...

2023-03-09 08:40:39 ET Ocean Biomedical ( OCEA ) +38% on sharing detailed research data on anti-tumor pathway discoveries and their potential for treatment of non-small cell lung cancer, metastatic melanoma, and glioblastoma by scientific co-founder. First Wave ( FWB...

NeuroOne® Awarded U.S. Patent Covering Novel and Proprietary Thin Film Electrode Platform PR Newswire New patent adds value to NeuroOne's growing patent portfolio in the U.S. and abroad EDEN PRAIRIE, Minn. , March 7, 2023 /PRNewswire/ -- NeuroOne...

NeuroOne Medical Technologies Corporation (NMTC) Q1 2023 Earnings Conference Call February 14, 2023, 04:30 AM ET Company Participants Dave Rosa - President and CEO Ron McClurg - CFO Conference Call Participants Alex Nowak - Craig Hallum Capital Group Ben Ha...

NeuroOne Medical Technologies press release ( NASDAQ: NMTC ): Net loss was $1.7 million for the fiscal first quarter 2023, compared to a net loss of $2.8 million in the prior year period. Product revenue was $115,000 in the fiscal first quarter 2023, ...

NeuroOne® Reports First Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update PR Newswire EDEN PRAIRIE, Minn. , Feb. 14, 2023 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical...

NeuroOne® to Report First Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on February 14 PR Newswire EDEN PRAIRIE, Minn. , Feb. 9, 2023 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Com...

NeuroOne® Issues Letter to Shareholders PR Newswire Company highlights fiscal year 2022 and subsequent achievements, catalysts for fiscal year 2023 EDEN PRAIRIE, Minn. , Jan. 30, 2023 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq:...

NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2022 Financial Results PR Newswire EDEN PRAIRIE, Minn. , Dec. 22, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC; "NeuroOne" or the "Company"), a medical technolo...

Palm Beach, FL – December 14, 2022 – FinancialNewsMedia.com News Commentary – A cardiac arrhythmia is an irregular heartbeat caused by incorrect electrical signals that govern the beats of the heart. The improper signaling pathway causes the heart to beat too rapi...